DUX4 and polymyositis: DUX4 suppresses MHC class I in cancer (Chew et al, 2019), and so may also be protective in FSHD by preventing infiltration of non‐necrotic fibres by endomysial CD8+ T‐cell infiltrates, as occurs in polymyositis.